IN8BIO, Inc.
NASDAQ:INAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
US |
|
A
|
Aspo Oyj
F:ZYD
|
FI |
|
B
|
BHP Group Ltd
XMUN:BHP1
|
AU |
|
A
|
AIA Group Ltd
F:7A2
|
HK |
|
N
|
Nexon Co Ltd
XMUN:7NX
|
JP |
|
I
|
Inari Amertron Bhd
KLSE:INARI
|
MY |
|
A
|
Ameriprise Financial Inc
DUS:A4S
|
US |
|
S
|
SBA Communications Corp
SWB:4SB
|
US |
|
S
|
Snap Inc
F:1SI
|
US |
|
T
|
Toyota Motor Corp
LSE:TYT
|
JP |
|
Black Hills Corp
NYSE:BKH
|
US |
|
D
|
Deutsche Bank AG
MIL:1DBK
|
DE |
|
Universal Music Group NV
F:0VD
|
NL |
|
V
|
Ventas Inc
SWB:VEN
|
US |
|
Simona AG
F:SIM0
|
DE |
|
S
|
Sasol Ltd
JSE:SOL
|
ZA |
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
|
JP |
|
Prosegur Compania de Seguridad SA
F:PRHA
|
ES |
|
Site Centers Corp
NYSE:SITC
|
US |
|
Dropbox Inc
NASDAQ:DBX
|
US |
|
B
|
Bureau Veritas SA
OTC:BVVBY
|
FR |
|
P
|
Paychex Inc
XMUN:PCX
|
US |
|
N
|
Nintendo Co Ltd
F:NTO
|
JP |
|
Britannia Industries Ltd
BSE:500825
|
IN |
Bankruptcy Probability
IN8BIO, Inc.'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IN8BIO, Inc. Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
IN8BIO, Inc.
NASDAQ:INAB
|
13.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IN8BIO, Inc.'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IN8BIO, Inc. has no debt.
You can find a full breakdown on its Balance Sheet.